Chinese maker of chromatography packing materials and silica microspheres used in biopharma purification.
Chinese maker of chromatography packing materials and silica microspheres used in biopharma purification.
Packing materials are consumables: once a drug maker writes one into the approved purification step for a biologic, it is bought again as columns wear out, so early qualification is the key sale. The silica microspheres that form the base of the packing are also sold on their own.
In one line: A China-based chromatography-media specialist.
Moat: narrow (process know-how, customer qualification). Purification media must be qualified into biologics manufacturing processes.
Headquarters: Suzhou, China · Employees: 1,213
Size Suzhou Nanomicro Technology (688690.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $2.08B, the 1128th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥34.36 on 18 Nov 2026.
Performance Over six months the shares fell 1.0%, against -1.7% for the median peer and -20.0% for the China market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue grew 26.4% over the last twelve months (peer median +15.8%); the operating margin is 24.8% (peer median 12.4%).
Valuation It trades at 51.5× forward earnings against a peer median of 17.0× (6th most expensive of 18).
Price implies For today's price to make sense, revenue must grow about 33% a year for seven years (Req g). Recent delivered growth is +35%, so the hurdle is -2 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 0.5 points above its cost of capital (11.9% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.14B | CN¥916M | CN¥777M | CN¥587M | CN¥699M |
| Revenue growth | — | +18% | +32% | -16% | — |
| Gross profit | CN¥837M | CN¥609M | CN¥505M | CN¥435M | CN¥533M |
| EBITDA | n/a | CN¥246M | CN¥185M | CN¥105M | CN¥259M |
| Net income | CN¥250M | CN¥136M | CN¥82.8M | CN¥68.6M | CN¥275M |
| Free cash flow | CN¥259M | CN¥82.7M | -CN¥6.36M | CN¥980,160 | -CN¥43.8M |
| Capital expenditure | CN¥97.2M | CN¥85.6M | CN¥139M | CN¥125M | CN¥156M |
| Total debt | CN¥22.2M | CN¥66.4M | CN¥134M | CN¥219M | CN¥172M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Suzhou Nanomicro Technology 688690.SS | $2.08B | -1% | +26% | 25% | 51.5× | 33.2% |
| Tosoh 4042.T | $4.93B | -5% | +6% | 9% | 12.2× | n/a |
| Repligen RGEN | $11.0B | +55% | +14% | 9% | 71.0× | 56.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688690.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -15.6% | +2.9% | 5th lowest of 21 |
| 6-month return | -1.0% | -1.7% | 11th highest of 21 |
| Distance from 52-week high | -31.6% | -28.2% | 9th lowest of 21 |
| Revenue growth (TTM) | +26.4% | +15.8% | 7th highest of 20 |
| Operating margin | 24.8% | 12.4% | 4th highest of 21 |
| Forward P/E | 51.5× | 17.0× | 6th most expensive of 18 |
| Growth the price implies (Req g, 7 yrs) | 33.2% | 13.7% | 3rd most demanding of 15 |
| Growth delivered (Del g) | +35.2% | +11.4% | 3rd highest of 14 |
| Hurdle (Req g minus delivered) | -2.0 pp | -10.4 pp | 5th most demanding of 14 |
| ROIC minus cost of capital | +0.5 pp | +0.8 pp | 10th lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Suzhou Nanomicro Technology 688690.SS | China | $2.08B | -1% | +26% | 25% | 51.5× | 33.2% | +35.2% |
| Biocytogen Pharmaceuticals (Beijing) 688796.SS | China | $2.09B | -33% | +40% | 24% | 73.0× | 31.0% | +41.1% |
| Sigurd Microelectronics 6257.TW | Taiwan | $2.10B | -28% | +18% | 24% | 11.3× | n/a | n/a |
| International Gemological Institute IGIL.NS | India | $2.05B | +33% | +21% | 58% | 26.0× | 16.3% | +37.6% |
| Firstsource Solutions FSL.NS | India | $2.04B | +13% | +20% | 12% | 20.4× | 19.2% | +13.5% |
| TIC Solutions TIC | United States | $2.15B | +14% | +39% | -1% | n/a | 32.6% | n/a |
| Heron Neutron Medical 7799.TW | Taiwan | $2.15B | +56% | n/a | -5,319% | 355.2× | n/a | n/a |
| Ardentec 3264.TWO | Taiwan | $2.17B | -26% | +32% | 30% | 11.3× | n/a | n/a |
| Sagility SAGILITY.NS | India | $2.26B | +7% | +28% | 18% | 17.0× | 11.2% | +19.5% |
| Hui Lyu Ecological Technology Groups 001267.SZ | China | $2.28B | -68% | +90% | 10% | 133.5× | n/a | n/a |
| KWS SAAT SE & Co KGaA KWS.DE | Germany | $2.30B | -11% | -1% | 13% | 12.7× | -6.0% | +4.4% |
| Syngene International SYNGENE.NS | India | $1.88B | -8% | -6% | 13% | 70.7× | 36.4% | +11.4% |
| China Automotive Engineering Research Institute 601965.SS | China | $2.31B | -11% | +12% | 24% | 13.8× | -4.7% | +7.9% |
| Jiangsu Guotai International 002091.SZ | China | $1.87B | -15% | +7% | 6% | 9.7× | -21.2% | +5.5% |
| Insperity NSP | United States | $1.86B | +55% | +2% | 0% | 19.6× | 19.4% | +9.7% |
| CECEP Environmental Protection 300140.SZ | China | $2.37B | -23% | -2% | 23% | n/a | -1.9% | +26.0% |
| Shanghai GenTech 688596.SS | China | $2.37B | +4% | +4% | 2% | 68.2× | n/a | n/a |
| Prosegur Compania de Seguridad PSG.MC | Spain | $1.82B | +10% | +4% | 6% | 12.2× | -3.7% | +6.7% |
| V2X VVX | United States | $2.45B | +9% | +13% | 4% | 11.7× | -0.5% | +26.3% |
| Beijing Orient EcoEnergy 002310.SZ | China | $1.75B | -25% | +35% | 12% | n/a | 36.0% | -47.6% |
| Hoist Finance HOFI.ST | Sweden | $1.75B | +20% | +16% | 30% | 12.2× | n/a | n/a |